Elevation of stromal cell-derived factor 1 and C-X-C chemokine receptor type 4 in white matter damage treatment with recombinant human erythropoietin and human umbilical cord mesenchymal stem cells in a rat model of preterm birth
- PMID: 32108377
- DOI: 10.1002/jdn.10021
Elevation of stromal cell-derived factor 1 and C-X-C chemokine receptor type 4 in white matter damage treatment with recombinant human erythropoietin and human umbilical cord mesenchymal stem cells in a rat model of preterm birth
Abstract
Objectives: To investigate the role of stromal cell-derived factor 1 (SDF-1) and C-X-C chemokine receptor type 4 (CXCR-4) in the premature brain with white matter damage (WMD) undergoing treatment with human umbilical cord mesenchymal stem cells (hUC-MSCs) and recombinant human erythropoietin (rhEPO).
Experimental design: Three-day-old Sprague-Dawley (SD) rats were randomly divided into sham operation group, hypoxia-ischemia (HI) group, rhEPO treated HI group, hUC-MSCs treated HI group, and rhEPO + hUC-MSCs treated HI group. WMD was established in all groups except the Sham group. SDF-1 and CXCR-4 levels in each group were detected at postnatal day (P) 5, P7, and P14. Pathological changes were assessed via HE staining at P14 and neuroethological tests were performed at P28.
Observations and conclusions: The rhEPO and hUC-MSCs intervention reduced injury area, increased body weight at P7, and improved neurobehavioral scores at P28. Furthermore, their combined use proved even more beneficial. SDF-1 levels in the rhEPO group were higher than those in the other groups and highest in the hUC-MSCs + rhEPO group (all p < .01). SDF-1 levels in the hUC-MSCs + rhEPO and rhEPO groups were increased at P5 and reached a peak at P7. CXCR-4 levels in the hUC-MSCs group were higher than those in the other groups and highest in the hUC-MSCs + rhEPO group (all p < .01). CXCR-4 levels were also increased at P5 and highest at P14.
Significance: hUC-MSCs + rhEPO might reduce nerve cell damage and improve neurobehavioral development, in connection with increased SDF-1 and CXCR-4 expression, in premature rats with WMD due to hypoxic-ischemic injury.
Keywords: CXC family chemokine 4; human umbilical cord mesenchymal stem cells; hypoxia-ischemia; premature rats; recombinant human erythropoietin; stromal cell-derived factor 1; white matter damage.
© 2020 International Society for Developmental Neuroscience.
Similar articles
-
Transplantation of RADA16-BDNF peptide scaffold with human umbilical cord mesenchymal stem cells forced with CXCR4 and activated astrocytes for repair of traumatic brain injury.Acta Biomater. 2016 Nov;45:247-261. doi: 10.1016/j.actbio.2016.09.001. Epub 2016 Sep 2. Acta Biomater. 2016. PMID: 27592818
-
Transplanted hUCB-MSCs migrated to the damaged area by SDF-1/CXCR4 signaling to promote functional recovery after traumatic brain injury in rats.Neurol Res. 2015 Jan;37(1):50-6. doi: 10.1179/1743132814Y.0000000399. Epub 2014 Jun 12. Neurol Res. 2015. PMID: 24919714
-
[Repair effect of different doses of human umbilical cord mesenchymal stem cells on white matter injury in neonatal rats].Zhongguo Dang Dai Er Ke Za Zhi. 2024 Apr 15;26(4):394-402. doi: 10.7499/j.issn.1008-8830.2310081. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 38660904 Free PMC article. Chinese.
-
Human Umbilical Cord Mesenchymal Stem Cells' Cultivation and Treatment of Liver Diseases.Curr Stem Cell Res Ther. 2023;18(3):286-298. doi: 10.2174/1574888X17666220623111406. Curr Stem Cell Res Ther. 2023. PMID: 35747963 Review.
-
Therapeutic effects of different intervention forms of human umbilical cord mesenchymal stem cells in the treatment of osteoarthritis.Front Cell Dev Biol. 2023 Aug 10;11:1246504. doi: 10.3389/fcell.2023.1246504. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37635870 Free PMC article. Review.
Cited by
-
Immunomodulatory Mechanism and Potential Therapies for Perinatal Hypoxic-Ischemic Brain Damage.Front Pharmacol. 2020 Dec 11;11:580428. doi: 10.3389/fphar.2020.580428. eCollection 2020. Front Pharmacol. 2020. PMID: 33536907 Free PMC article. Review.
-
Human Umbilical Cord Mesenchymal Stem Cells Attenuate Severe Burn-Induced Multiple Organ Injury via Potentiating IGF-1 and BCL-2/BAX Pathway.Stem Cells Int. 2022 Dec 23;2022:5474289. doi: 10.1155/2022/5474289. eCollection 2022. Stem Cells Int. 2022. PMID: 36591374 Free PMC article.
References
REFERENCES
-
- Askari, A. T., & Penn, M. S. (2009). Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration. Discovery Medicine, 3, 46-47.
-
- Back, S. A. (2017). White matter injury in the preterm infant: Pathology and mechanisms. Acta Neuropathologica, 134, 1-19.
-
- Back, S. A., Han, B. H., Luo, N. L., Chricton, C. A., Xanthoudakis, S., Tam, J., … Holtzman, D. M. (2002). Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. Journal of Neuroscience the Official Journal of the Society for Neuroscience, 22(2), 455-463.
-
- Back, S. A., Luo, N. L., Borenstein, N. S., Levine, J. M., Volpe, J. J., & Kinney, H. C. (2001). Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. Journal of Neuroscience, 21, 1302-1312.
-
- Bhakta, S., Hong, P., & Koc, O. (2006). The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovascular Revascularization Medicine, 7, 19-24.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous